Prevention of Herpes Zoster
2 clinical trials · Condition
◉ Watch Prevention of Herpes Zoster
| Record | Firm | Date |
|---|---|---|
| Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043) (NCT00561080) | Merck Sharp & Dohme LLC | 2007-10-26 |
Track Prevention of Herpes Zoster automatically
Every clearance here is in the API, with alerts when new ones post.